Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Gernert

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Design and synthesis of benzofused heterocyclic RXR modulatorsD L Gernert, D A Neel, M F Boehm, et al.
Canadian Journal of Physiology and Pharmacology|June 1, 1997
In vitro studies of a bradykinin B1/B2 antagonist linked to a human neutrophil elastase inhibitor; a heterodimer for the treatment of inflammatory disordersA H Leimer, H B Kroona, J K Blodgett, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Design and synthesis of fluorinated RXR modulatorsD L Gernert, R Ajamie, R A Ardecky, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2014
Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent modelsR Zwart, E Sher, X Ping, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Design and synthesis of benzofused heterocyclic RXR modulatorsD L Gernert, D A Neel, M F Boehm, et al.
Canadian Journal of Physiology and Pharmacology|June 1, 1997
In vitro studies of a bradykinin B1/B2 antagonist linked to a human neutrophil elastase inhibitor; a heterodimer for the treatment of inflammatory disordersA H Leimer, H B Kroona, J K Blodgett, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Design and synthesis of fluorinated RXR modulatorsD L Gernert, R Ajamie, R A Ardecky, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2014
Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent modelsR Zwart, E Sher, X Ping, et al.
Pageof 1